Benjamin T Schleenvoigt1, Ralf Ignatius2, Michael Baier3, Thomas Schneider4, Marko Weber5, Stefan Hagel6,5, Christina Forstner6,7, Mathias W Pletz6. 1. Center for Infectious Diseases and Infection Control, Jena University Hospital, Erlanger Allee 101, 07740, Jena, Thuringia, Germany. benjamin.schleenvoigt@med.uni-jena.de. 2. Institute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany. 3. Institute for Medical Microbiology, Jena University Hospital, Jena, Germany. 4. Department of Internal Medicine - Gastroenterology, Infectious Diseases, and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany. 5. Department of Internal Medicine IV, Jena University Hospital, Jena, Germany. 6. Center for Infectious Diseases and Infection Control, Jena University Hospital, Erlanger Allee 101, 07740, Jena, Thuringia, Germany. 7. Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Abstract
CASE PRESENTATION: Here, we report on a case of VL in an HIV-infected patient from the Republic of Georgia who had moved to Germany 14 years before and who had travelled several times to southern Europe in between. After presenting with typical Pneumocystis jiroveci pneumonia, which was treated appropriately, the patient was started on antiretroviral therapy. Shortly thereafter, however, he developed fever of unknown origin. All laboratory assays for the diagnosis of various infectious agents including serological assays and polymerase chain reaction testing of bone marrow aspirate to diagnose VL did not yield positive results at first. Only upon repetition of these tests, diagnosis of VL could be made and the patient treated accordingly. CASE DISCUSSION: Visceral leishmaniasis (VL) is a common opportunistic infection in HIV-positive patients from endemic countries but occurs rarely following antiretroviral treatment. This case demonstrates that patients who develop VL upon immune reconstitution may not be diagnosed initially by standard laboratory assays for the diagnosis of VL and underlines the necessity to repeat serologic and molecular biologic testing for VL in cases of fever of unknown origin in patients from or with travel history to endemic countries.
CASE PRESENTATION: Here, we report on a case of VL in an HIV-infectedpatient from the Republic of Georgia who had moved to Germany 14 years before and who had travelled several times to southern Europe in between. After presenting with typical Pneumocystis jiroveci pneumonia, which was treated appropriately, the patient was started on antiretroviral therapy. Shortly thereafter, however, he developed fever of unknown origin. All laboratory assays for the diagnosis of various infectious agents including serological assays and polymerase chain reaction testing of bone marrow aspirate to diagnose VL did not yield positive results at first. Only upon repetition of these tests, diagnosis of VL could be made and the patient treated accordingly. CASE DISCUSSION: Visceral leishmaniasis (VL) is a common opportunistic infection in HIV-positivepatients from endemic countries but occurs rarely following antiretroviral treatment. This case demonstrates that patients who develop VL upon immune reconstitution may not be diagnosed initially by standard laboratory assays for the diagnosis of VL and underlines the necessity to repeat serologic and molecular biologic testing for VL in cases of fever of unknown origin in patients from or with travel history to endemic countries.
Entities:
Keywords:
HIV infection; IRIS; Immune reconstitution inflammatory syndrome; Visceral leishmaniasis
Authors: R de la Rosa ; J A Pineda; J Delgado; J Macías; F Morillas; J Martín-Sánchez; M Leal; A Sánchez-Quijano; E Lissen Journal: Clin Infect Dis Date: 2001-02-06 Impact factor: 9.079
Authors: Rachel ter Horst; Simon M Collin; Koert Ritmeijer; Adey Bogale; Robert N Davidson Journal: Clin Infect Dis Date: 2008-06-01 Impact factor: 9.079
Authors: Cristina Mussini; Christian Manzardo; Margaret Johnson; Antonella d'Arminio Monforte; Caterina Uberti-Foppa; Andrea Antinori; M John Gill; Laura Sighinolfi; Vanni Borghi; Adriano Lazzarin; José M Miró; Caroline Sabin Journal: AIDS Date: 2008-11-30 Impact factor: 4.177
Authors: J Thoden; A Potthoff; J R Bogner; N H Brockmeyer; S Esser; K Grabmeier-Pfistershammer; B Haas; K Hahn; G Härter; M Hartmann; C Herzmann; J Hutterer; A R Jordan; C Lange; S Mauss; D Meyer-Olson; F Mosthaf; M Oette; S Reuter; A Rieger; T Rosenkranz; M Ruhnke; B Schaaf; S Schwarze; H J Stellbrink; H Stocker; A Stoehr; M Stoll; C Träder; M Vogel; D Wagner; C Wyen; C Hoffmann Journal: Infection Date: 2013-09-14 Impact factor: 3.553
Authors: José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira Journal: HIV AIDS (Auckl) Date: 2016-10-07